Sept. 14, 2026 — Interventional Medical Device Solutions (IMDS), has announced the U.S. launch of NHanceIT, an over-the ...
Sept. 8, 2026 — Penumbra recently launched the Link clot capture device designed to support the removal of arterial ...
The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Sept. 9, 2026— Atman Health has been selected by the Advanced Research Projects Agency for Health (ARPA-H) to develop an ...
Sept. 9, 2026 —The Nicklaus Children's Hospital Heart Institute has successfully performed one of the first Fontan ...
Aug. 29, 2026— Vesalio recently announced results from the NATURE trial (NCT04969471), a prospective, randomized ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Sept. 8, 2026 — New research1 indicates that people with invasive cancer face an elevated risk of experiencing a stroke ...
Aug. 27, 2026 — Artificial intelligence is fundamentally reshaping the cardiovascular devices landscape, driven by a ...
Sept. 8, 2026 — Abbot has announced that it has received U.S. Food and Drug Administration (FDA) approval for the ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Sept. 2, 2026 — Heartvue.ai and Innolitics have announced the U.S. Food and Drug Administration has granted 510(k) ...
Aug. 31, 2026 — Caristo Diagnostics has announced new independent University of Oxford-led research showing that Caristo ...
Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...
Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...
Aug. 28, 2026 — Royal Philips and Imricor Medical Systems have announced a new Interventional MR (iMR) lab solution for ...
September 15, 2026
